138 related articles for article (PubMed ID: 37996642)
1. ASO Author Reflections: Impact of Universal Germline Genetic Testing on Clinical Management in Rural Breast Cancer Patients.
Shelton C; Nielsen SM
Ann Surg Oncol; 2024 Feb; 31(2):1007. PubMed ID: 37996642
[No Abstract] [Full Text] [Related]
2. ASO Author Reflections: Other Cancers in Patients with Breast Cancer Who Undergo Germline Testing.
Murphy BL; Arun BK
Ann Surg Oncol; 2023 May; 30(5):2914-2915. PubMed ID: 36705815
[No Abstract] [Full Text] [Related]
3. ASO Author Reflections: Germline Testing for All Patients With Breast Cancer: Has the Time Finally Come?
Mittal A; Pramanik R
Ann Surg Oncol; 2022 Feb; 29(2):1433-1434. PubMed ID: 34654988
[TBL] [Abstract][Full Text] [Related]
4. Universal Germline-Genetic Testing for Breast Cancer: Implementation in a Rural Practice and Impact on Shared Decision-Making.
Shelton C; Ruiz A; Shelton L; Montgomery H; Freas K; Ellsworth RE; Poll S; Pineda-Alvarez D; Heald B; Esplin ED; Nielsen SM
Ann Surg Oncol; 2024 Jan; 31(1):325-334. PubMed ID: 37814187
[TBL] [Abstract][Full Text] [Related]
5. Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer.
Whitworth PW; Beitsch PD; Patel R; Rosen B; Compagnoni G; Baron PL; Simmons R; Brown EA; Gold L; Holmes D; Smith LA; Kinney M; Grady I; Clark P; Barbosa K; Lyons S; Riley L; Coomer C; Curcio L; Ruiz A; Khan S; MacDonald H; Hughes K; Hardwick MK; Heald B; Munro SB; Nielsen SM; Esplin ED
JAMA Netw Open; 2022 Sep; 5(9):e2232787. PubMed ID: 36136330
[TBL] [Abstract][Full Text] [Related]
6. ASO Author Reflections: The Role of Surgeons and Nurse Specialists in the Mainstreaming of Genetic Testing for Breast Cancer Patients.
Bokkers K; Ausems MGEM
Ann Surg Oncol; 2023 Jun; 30(6):3259-3260. PubMed ID: 36826617
[No Abstract] [Full Text] [Related]
7. ASO Author Reflections: Oncotype DX RS Complementing the Prognostic Stage in the Updated AJCC 8th Edition for T
Wang M; Wu K; Chen H
Ann Surg Oncol; 2019 May; 26(5):1236-1237. PubMed ID: 30706224
[No Abstract] [Full Text] [Related]
8. ASO Author Reflections: A Green Light for Genetic Testing in All Patients with Breast Cancer.
Culver JO
Ann Surg Oncol; 2023 Feb; 30(2):1026-1027. PubMed ID: 36241948
[No Abstract] [Full Text] [Related]
9. ASO Author Reflections: The Pressing Need for Germline Genetic Testing.
Plichta JK; Hughes KS
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):612-613. PubMed ID: 31098782
[No Abstract] [Full Text] [Related]
10. Genetic counseling and management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations.
Silva E; Lynch H
Breast J; 2006; 12(3):280-1; author reply 282-4. PubMed ID: 16684334
[No Abstract] [Full Text] [Related]
11. ASO Author Reflections: Sentinel Lymph Node Biopsy in BRCA1/2 Germline Pathogenic Variant Carriers Undergoing Risk-Reducing Mastectomy.
Ferroum A; Wong SM
Ann Surg Oncol; 2022 Oct; 29(11):6669-6670. PubMed ID: 35711015
[No Abstract] [Full Text] [Related]
12. Universal genetic testing for women with newly diagnosed breast cancer in the context of multidisciplinary team care.
De Silva DL; Stafford L; Skandarajah AR; Sinclair M; Devereux L; Hogg K; Kentwell M; Park A; Lal L; Zethoven M; Jayawardana MW; Chan F; Butow PN; James PA; Mann GB; Campbell IG; Lindeman GJ
Med J Aust; 2023 May; 218(8):368-373. PubMed ID: 37005005
[TBL] [Abstract][Full Text] [Related]
13. Evidence Grows for Universal Germline Genetic Testing for Patients with Breast Cancer.
Am J Med Genet A; 2023 Feb; 191(2):319-320. PubMed ID: 36625774
[No Abstract] [Full Text] [Related]
14. ASO Author Reflections: How COVID-19 Impacted Breast Cancer Presentation and Management.
Tonneson JE; Boughey JC
Ann Surg Oncol; 2022 Apr; 29(4):2240-2241. PubMed ID: 34850303
[No Abstract] [Full Text] [Related]
15. Germline genetic testing for breast cancer: which patients? What genes?
Domchek SM
Genet Med; 2020 Apr; 22(4):698-700. PubMed ID: 31831880
[No Abstract] [Full Text] [Related]
16. Results from London Regional Clinical Genetics services over a 5-year period on germline
Garrett A; Talukdar S; Izatt L; Brady AF; Whyte S; Josephs KS; Shanmugasundaram M; Guillemot LS; Vakili D; Ey S; Ahmed M
J Med Genet; 2022 Jun; 59(6):554-558. PubMed ID: 34266904
[TBL] [Abstract][Full Text] [Related]
17. Genetic testing in women with breast cancer: implications for treatment.
Paterson R; Phillips KA
Expert Rev Anticancer Ther; 2017 Nov; 17(11):991-1002. PubMed ID: 28853307
[TBL] [Abstract][Full Text] [Related]
18. How to manage patients with moderate-risk germline mutations.
Tung NM
Clin Adv Hematol Oncol; 2018 Feb; 16(2):97-101. PubMed ID: 29741508
[No Abstract] [Full Text] [Related]
19. ASO Author Reflections: Deeper Insight into Therapeutic Implications and Non-invasive Detection of Homologous Recombination Deficiency in Triple-Negative Breast Cancer: Results from a Multi-omics Cohort Study.
Su GH; Jiang L; Xiao Y; Zheng RC; Wang H; Jiang YZ; Peng WJ; Shao ZM; Gu YJ; You C
Ann Surg Oncol; 2022 Oct; 29(11):7176-7177. PubMed ID: 35644861
[No Abstract] [Full Text] [Related]
20. Changing landscape of hereditary breast and ovarian cancer germline genetic testing in Australia.
Petelin L; James PA; Trainer AH
Intern Med J; 2018 Oct; 48(10):1269-1272. PubMed ID: 30288903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
